Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)
Completed
- Conditions
- Human Immunodeficiency Virus
- Registration Number
- NCT00244803
- Lead Sponsor
- Johns Hopkins University
- Brief Summary
The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.
- Detailed Description
This research is being done to learn whether HIV-infected patients have abnormalities in their blood vessels that could eventually lead to heart attack or stroke (atherosclerosis), in how fat is distributed in their body and in how their body handles fat and sugars. If there are abnormalities, this study will also try to find out what factors may contribute to those abnormalitites.
People who participated in FRAM 1 may join FRAM 2.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 101
Inclusion Criteria
- 18-65 years old
- previous FRAM 1 participant
- HIV positive
Exclusion Criteria
- Artificial knee or hip replacement or Harrington rod
- Metal objects in the body.Pregnancy
- Breastfeeding or less than 3 months after breastfeeding
- Weight more than 300 pound
- On insulin, pancreatic enzymes, or thioridazine.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Johns Hopkins University, The Clinical Trials Unit
🇺🇸Baltimore, Maryland, United States